NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) Stock Rating Lowered by Zacks Investment Research

NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday, reports.

According to Zacks, “Nissan Chemical Corporation is a chemical manufacturing company. It offers melamine, sulfuric acid, nitric acid and ammonia; fine chemicals, including special epoxy, flame retardant and disinfectant. Nissan Chemical Corporation, formerly known as Nissan Chemical Industries Ltd., is based in Tokyo, Japan. “

Shares of OTCMKTS:NNCHY opened at $45.19 on Friday. NISSAN CHEM IND/ADR has a fifty-two week low of $41.85 and a fifty-two week high of $54.81. The business has a 50-day moving average of $43.72. The firm has a market capitalization of $6.73 billion, a PE ratio of 25.39, a P/E/G ratio of 2.26 and a beta of 0.53. The company has a quick ratio of 1.90, a current ratio of 3.10 and a debt-to-equity ratio of 0.01.

NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) last announced its quarterly earnings results on Wednesday, May 15th. The company reported $0.64 earnings per share for the quarter. The company had revenue of $572.13 million during the quarter. As a group, equities analysts forecast that NISSAN CHEM IND/ADR will post 2 earnings per share for the current fiscal year.


Nissan Chemical Corporation engages in chemicals, performance materials, agricultural chemicals, pharmaceuticals, and advanced materials and planning businesses in Japan and internationally. Its chemical products include MELAMINE, an adhesive agent; high purity chemicals; AdBlue, a urea solution; FINEOXOCOL, a saturated fatty alcohol and acid; ammonia, sulfuric, and nitric acid; TEPIC, an epoxy compound; Melamine Cyanurate, a flame retardant; Nissan Reishi, a health food; phenylphosphonic acid, a surface modifier; HI-LITE, a chlorinated isocyanulate; and OPTBEADS, a melamine-formaldehyde resin and silica.

Featured Article: Why Net Income is Important to Investors

Get a free copy of the Zacks research report on NISSAN CHEM IND/ADR (NNCHY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for NISSAN CHEM IND/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NISSAN CHEM IND/ADR and related companies with's FREE daily email newsletter.